110 related articles for article (PubMed ID: 21147531)
1. 2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacy.
Sweis RF; Hunt JA; Kallashi F; Hammond ML; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Rosa R; Peterson L; Sparrow CP; Wright SD; Anderson MS; Sinclair PJ
Bioorg Med Chem Lett; 2011 Mar; 21(6):1890-5. PubMed ID: 21147531
[TBL] [Abstract][Full Text] [Related]
2. 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: attenuation of hERG binding and improved HDLc-raising efficacy.
Sweis RF; Hunt JA; Sinclair PJ; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Rosa R; Peterson L; Sparrow CP; Anderson MS
Bioorg Med Chem Lett; 2011 May; 21(9):2597-600. PubMed ID: 21398121
[TBL] [Abstract][Full Text] [Related]
3. 2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.
Kallashi F; Kim D; Kowalchick J; Park YJ; Hunt JA; Ali A; Smith CJ; Hammond ML; Pivnichny JV; Tong X; Xu SS; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Peterson LB; Rosa R; Sparrow CP; Wright SD; Sinclair PJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):558-61. PubMed ID: 21094047
[TBL] [Abstract][Full Text] [Related]
4. 2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety.
Smith CJ; Ali A; Chen L; Hammond ML; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Sparrow CP; Wright SD; Sinclair PJ
Bioorg Med Chem Lett; 2010 Jan; 20(1):346-9. PubMed ID: 19914065
[TBL] [Abstract][Full Text] [Related]
5. 2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesis.
Harikrishnan LS; Kamau MG; Herpin TF; Morton GC; Liu Y; Cooper CB; Salvati ME; Qiao JX; Wang TC; Adam LP; Taylor DS; Chen AY; Yin X; Seethala R; Peterson TL; Nirschl DS; Miller AV; Weigelt CA; Appiah KK; O'Connell JC; Michael Lawrence R
Bioorg Med Chem Lett; 2008 Apr; 18(8):2640-4. PubMed ID: 18374566
[TBL] [Abstract][Full Text] [Related]
6. Biphenyl-substituted oxazolidinones as cholesteryl ester transfer protein inhibitors: modifications of the oxazolidinone ring leading to the discovery of anacetrapib.
Smith CJ; Ali A; Hammond ML; Li H; Lu Z; Napolitano J; Taylor GE; Thompson CF; Anderson MS; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Sparrow CP; Wright SD; Cumiskey AM; Latham M; Peterson LB; Rosa R; Pivnichny JV; Tong X; Xu SS; Sinclair PJ
J Med Chem; 2011 Jul; 54(13):4880-95. PubMed ID: 21682257
[TBL] [Abstract][Full Text] [Related]
7. SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors.
Lu Z; Chen YH; Napolitano JB; Taylor G; Ali A; Hammond ML; Deng Q; Tan E; Tong X; Xu SS; Latham MJ; Peterson LB; Anderson MS; Eveland SS; Guo Q; Hyland SA; Milot DP; Chen Y; Sparrow CP; Wright SD; Sinclair PJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):199-203. PubMed ID: 22142541
[TBL] [Abstract][Full Text] [Related]
8. Chromanol derivatives--a novel class of CETP inhibitors.
Vakalopoulos A; Schmeck C; Thutewohl M; Li V; Bischoff H; Lustig K; Weber O; Paulsen H; Elias H
Bioorg Med Chem Lett; 2011 Jan; 21(1):488-91. PubMed ID: 21084191
[TBL] [Abstract][Full Text] [Related]
9. Design of a novel class of biphenyl CETP inhibitors.
Lu Z; Napolitano JB; Theberge A; Ali A; Hammond ML; Tan E; Tong X; Xu SS; Latham MJ; Peterson LB; Anderson MS; Eveland SS; Guo Q; Hyland SA; Milot DP; Chen Y; Sparrow CP; Wright SD; Sinclair PJ
Bioorg Med Chem Lett; 2010 Dec; 20(24):7469-72. PubMed ID: 21041082
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors.
Wang A; Prouty CP; Pelton PD; Yong M; Demarest KT; Murray WV; Kuo GH
Bioorg Med Chem Lett; 2010 Feb; 20(4):1432-5. PubMed ID: 20089400
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure-activity-relationship of 1,5-tetrahydronaphthyridines as CETP inhibitors.
Fernandez MC; Escribano A; Mateo AI; Parthasarathy S; Martin de la Nava EM; Wang X; Cockerham SL; Beyer TP; Schmidt RJ; Cao G; Zhang Y; Jones TM; Borel A; Sweetana SA; Cannady EA; Stephenson G; Frank S; Mantlo NB
Bioorg Med Chem Lett; 2012 May; 22(9):3056-62. PubMed ID: 22497761
[TBL] [Abstract][Full Text] [Related]
12. Reliable structural information for rational design of benzoxazole type potential cholesteryl ester transfer protein (CETP) inhibitors through multiple validated modeling techniques.
Amin SA; Adhikari N; Gayen S; Jha T
J Biomol Struct Dyn; 2019 Oct; 37(17):4528-4541. PubMed ID: 30488780
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein.
Reinhard EJ; Wang JL; Durley RC; Fobian YM; Grapperhaus ML; Hickory BS; Massa MA; Norton MB; Promo MA; Tollefson MB; Vernier WF; Connolly DT; Witherbee BJ; Melton MA; Regina KJ; Smith ME; Sikorski JA
J Med Chem; 2003 May; 46(11):2152-68. PubMed ID: 12747787
[TBL] [Abstract][Full Text] [Related]
14. Refocusing on use of cholesteryl ester transfer protein inhibitors.
Kastelein JJ
Am J Cardiol; 2007 Dec; 100(11 A):n47-52. PubMed ID: 18047853
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors.
Escribano A; Mateo AI; Martin de la Nava EM; Mayhugh DR; Cockerham SL; Beyer TP; Schmidt RJ; Cao G; Zhang Y; Jones TM; Borel AG; Sweetana SA; Cannady EA; Mantlo NB
Bioorg Med Chem Lett; 2012 Jun; 22(11):3671-5. PubMed ID: 22543028
[TBL] [Abstract][Full Text] [Related]
16. Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
Hansen MK; McVey MJ; White RF; Legos JJ; Brusq JM; Grillot DA; Issandou M; Barone FC
J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):196-202. PubMed ID: 20332533
[TBL] [Abstract][Full Text] [Related]
17. Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors.
Eary CT; Jones ZS; Groneberg RD; Burgess LE; Mareska DA; Drew MD; Blake JF; Laird ER; Balachari D; O'Sullivan M; Allen A; Marsh V
Bioorg Med Chem Lett; 2007 May; 17(9):2608-13. PubMed ID: 17331716
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of (2R,alphaS)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-alpha-(trifluoromethyl)-1(2H)-quinolineethanol as potent and orally active cholesteryl ester transfer protein inhibitor.
Kuo GH; Rano T; Pelton P; Demarest KT; Gibbs AC; Murray WV; Damiano BP; Connelly MA
J Med Chem; 2009 Mar; 52(6):1768-72. PubMed ID: 19236017
[TBL] [Abstract][Full Text] [Related]
19. Novel tetrahydrochinoline derived CETP inhibitors.
Schmeck C; Gielen-Haertwig H; Vakalopoulos A; Bischoff H; Li V; Wirtz G; Weber O
Bioorg Med Chem Lett; 2010 Mar; 20(5):1740-3. PubMed ID: 20137927
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform.
Rano TA; Sieber-McMaster E; Pelton PD; Yang M; Demarest KT; Kuo GH
Bioorg Med Chem Lett; 2009 May; 19(9):2456-60. PubMed ID: 19339179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
